Fortress Biotech, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US34960Q3074
USD
2.75
0.18 (7.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fortress Biotech, Inc.
Assembly Biosciences, Inc.
Sol-Gel Technologies Ltd.
Societal CDMO, Inc.
Clearside Biomedical, Inc.
Rezolute, Inc.
SELLAS Life Sciences Group, Inc.
MEI Pharma, Inc.
Minerva Neurosciences, Inc.
Kineta, Inc.
SciSparc Ltd.
Why is Fortress Biotech, Inc. ?
1
With a growth in Net Sales of 24.92%, the company declared Very Positive results in Jun 25
  • OPERATING CASH FLOW(Y) Highest at USD -80.09 MM
  • ROCE(HY) Highest at -47.67%
  • RAW MATERIAL COST(Y) Fallen by -18.05% (YoY)
2
High Institutional Holdings at 30.39%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 0.66% over the previous quarter.
3
Market Beating Performance
  • The stock has generated a return of 60.12% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Fortress Biotech, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Fortress Biotech, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Fortress Biotech, Inc.
25.57%
0.48
78.34%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.50%
EBIT Growth (5y)
-1.74%
EBIT to Interest (avg)
-10.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.39
Sales to Capital Employed (avg)
0.79
Tax Ratio
0.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
30.39%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.66
EV to EBIT
-0.29
EV to EBITDA
-0.31
EV to Capital Employed
-3.25
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-482.55%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -80.09 MM

ROCE(HY)

Highest at -47.67%

RAW MATERIAL COST(Y)

Fallen by -18.05% (YoY

NET SALES(Q)

Highest at USD 16.41 MM

PRE-TAX PROFIT(Q)

Highest at USD -11.3 MM

NET PROFIT(Q)

Highest at USD 15.84 MM

EPS(Q)

Highest at USD 0.45

-3What is not working for the Company
OPERATING PROFIT(Q)

Lowest at USD -34.83 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -212.22 %

Here's what is working for Fortress Biotech, Inc.
Net Profit
At USD 15.84 MM has Grown at 250.79%
over average net sales of the previous four periods of USD -10.5 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD -80.09 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 16.41 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Pre-Tax Profit
Highest at USD -11.3 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -11.3 MM has Grown at 57.73%
over average net sales of the previous four periods of USD -26.74 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 15.84 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.45
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -18.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Fortress Biotech, Inc.
Operating Profit
Lowest at USD -34.83 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at -212.22 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales